JP2006522775A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522775A5
JP2006522775A5 JP2006505540A JP2006505540A JP2006522775A5 JP 2006522775 A5 JP2006522775 A5 JP 2006522775A5 JP 2006505540 A JP2006505540 A JP 2006505540A JP 2006505540 A JP2006505540 A JP 2006505540A JP 2006522775 A5 JP2006522775 A5 JP 2006522775A5
Authority
JP
Japan
Prior art keywords
het
group
alkyl
phenyl
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006505540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006522775A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/050492 external-priority patent/WO2004089372A1/en
Publication of JP2006522775A publication Critical patent/JP2006522775A/ja
Publication of JP2006522775A5 publication Critical patent/JP2006522775A5/ja
Withdrawn legal-status Critical Current

Links

JP2006505540A 2003-04-11 2004-04-08 置換された4−フェニル−4−’1h−イミダゾール−2−イル!−ピペリジン誘導体および抗抑鬱および不安緩解活性を有する選択性非ペプチドデルタオピオイドアゴニストとしてのそれらの使用 Withdrawn JP2006522775A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0303879 2003-04-11
PCT/EP2004/050492 WO2004089372A1 (en) 2003-04-11 2004-04-08 Substituted 4-phenyl-4-`1h-imidazol-2-yl !-piperidine derivatives and their use as selective non-peptide delta opioid agonists with antidepressant and anxiolytic activity

Publications (2)

Publication Number Publication Date
JP2006522775A JP2006522775A (ja) 2006-10-05
JP2006522775A5 true JP2006522775A5 (https=) 2007-06-07

Family

ID=33154992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505540A Withdrawn JP2006522775A (ja) 2003-04-11 2004-04-08 置換された4−フェニル−4−’1h−イミダゾール−2−イル!−ピペリジン誘導体および抗抑鬱および不安緩解活性を有する選択性非ペプチドデルタオピオイドアゴニストとしてのそれらの使用

Country Status (12)

Country Link
US (1) US20060287345A1 (https=)
EP (1) EP1615644B1 (https=)
JP (1) JP2006522775A (https=)
AR (1) AR044010A1 (https=)
AT (1) ATE353649T1 (https=)
AU (1) AU2004228960A1 (https=)
CA (1) CA2521186A1 (https=)
CL (1) CL2004000754A1 (https=)
DE (1) DE602004004771T2 (https=)
ES (1) ES2282858T3 (https=)
TW (1) TW200509913A (https=)
WO (1) WO2004089372A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2149370A1 (en) 2008-07-31 2010-02-03 Neuroscienze Pharmaness S.C. A R.L. Diazabicyclic compounds and microemulsions thereof
IT1390848B1 (it) 2008-07-31 2011-10-19 Neuroscienze Pharmaness S C A R L Composti farmaceutici
JP2011030565A (ja) * 2009-07-06 2011-02-17 Yokohama City Univ 社会的隔離モデル動物
IT1396951B1 (it) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
ES2770978T3 (es) * 2013-05-24 2020-07-06 Alkermes Pharma Ireland Ltd Análogos de morfanos y morfinanos y métodos de uso
CN113292558A (zh) 2015-03-17 2021-08-24 日本化学药品株式会社 吗啡喃衍生物
WO2018030382A1 (ja) 2016-08-09 2018-02-15 国立大学法人 筑波大学 モルヒナン誘導体
WO2018052114A1 (ja) 2016-09-16 2018-03-22 国立大学法人 筑波大学 モルヒナン誘導体のオピオイドδ受容体アゴニスト関連疾患の治療のための使用
RS66290B1 (sr) 2018-05-01 2025-01-31 Merck Sharp & Dohme Llc Spiropiperidin alosterični modulatori nikotinskih acetiholinskih receptora
US20230141198A1 (en) 2019-11-22 2023-05-11 The Kitasato Institute Pyrazolomorphinan derivative
AU2022225712A1 (en) 2021-02-26 2023-09-07 Nippon Chemiphar Co., Ltd. Pharmaceutical composition for treatment or prevention of stress-related disorders
AU2022245394A1 (en) * 2021-03-26 2023-10-12 Px Ing, Llc The use of paraxanthine to reduce exercise-induced mental fatigue

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
HN1999000149A (es) * 1998-09-09 2000-01-12 Pfizer Prod Inc Derivados de 4,4-biarilpiperidina
EP1038872A1 (en) * 1999-02-22 2000-09-27 Pfizer Products Inc. 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
SE0101767D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
NZ531733A (en) * 2001-10-15 2006-04-28 Janssen Pharmaceutica Nv Substituted 4-phenyl-4-[1H-imidazol-2-YL]- piperidine derivatives for reducing ischaemic damage
BR0213327A (pt) * 2001-10-15 2004-10-13 Janssen Pharmaceutica Nv Derivados de 4-fenil-4-[1h-imidazol-2-il]-piperidina substituìdos e sua aplicação como agonistas de delta opióides não-peptìdicos seletivos

Similar Documents

Publication Publication Date Title
RU2437882C2 (ru) Производные имидазолидинона
JP2009541311A5 (https=)
JP2022189853A5 (https=)
JP2006522775A5 (https=)
JP2008513514A5 (https=)
JP2011500806A5 (https=)
CA2642922A1 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
RU2015150946A (ru) Новые соединения для селективных ингибиторов гистондеацетилазы и фармацевтическая композиция, включающая такие соединения
JP2019530695A5 (https=)
EA018268B1 (ru) Аналоги пиридона и пиридазона как модуляторы gpr119
RU2008126398A (ru) Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpti)
PE20081228A1 (es) Compuesto heteromonociclico
JP2019513776A5 (https=)
JP2018530591A5 (https=)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
RU2008117329A (ru) Производные имидазопиридина как антагонисты аденозинового рецептора а2в
SI2855449T1 (en) SULFONYL PIPERIDIN DERIVATIVES AND THEIR USE IN TREATMENT OF PROKINETICINAL DISEASE DISEASES
EP2594270A2 (en) The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)
JP2014521623A5 (https=)
SI2981533T1 (en) Protein Protein Kinase
HRP20140252T1 (hr) Derivati imidazola kao inhibitori kazeinske kinaze
HRP20161797T1 (hr) Spojevi 1,3-oksazolidina ili 1,3-oksazinana kao antagonisti receptora oreksina
PE20081315A1 (es) Derivados de benzimidazol como antagonistas de vr-1
RU2017120217A (ru) 2-амино-5,5-дифтор-6-(фторметил)-6-фенил-3,4,5,6-тетрагидпропиридины в качестве ингибиторов bace1
CA2905530A1 (en) Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors